The HMG-CoA reductase pathway, statins and angioprevention

Seminars in Ophthalmology
Chong FengMengfeng Li

Abstract

Angiogenesis is one of the earliest and essential phenotypes acquired by tumors during carcinogenesis and thus might be a potential target for chemoprevention. Key to developing antiangiogenic chemoprevention is to identify new molecular targets and effective angiogenesis inhibitors. HMG-CoA reductase inhibitors, or statins, were originally designed to reduce cholesterol biosynthesis and have been extensively used as prevention drugs against hyperlipidemia and cardiovascular conditions. Recent research has found that statins promote endothelial death and inhibit experimental angiogenesis induced by growth factors or tumor, laying a foundation for developing statin-based angiopreventive strategies. This article reviews the biological effects of statins on endothelial cells and angiogenesis, possible underlying mechanisms and perspectives on future application of statins in preventing pathological angiogenesis.

References

Sep 1, 1989·International Journal of Radiation Oncology, Biology, Physics·S M Lippman, W K Hong
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Mar 30, 1994·Biochemical and Biophysical Research Communications·D Pérez-Sala, F Mollinedo
Apr 29, 1993·The New England Journal of Medicine·W C Black, H G Welch
Apr 7, 1997·Biochemical and Biophysical Research Communications·J Y MiaoH Hayashi
Dec 19, 1998·Journal of the American College of Cardiology·C BustosJ Egido
Apr 14, 1999·Nature·Y Cao, R Cao
Nov 5, 1999·Nature Medicine·S GarbisaA Albini
Jun 28, 2001·Leukemia & Lymphoma·J DimitroulakosL Z Penn
Jul 4, 2001·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·B Jiménez, O V Volpert
Sep 8, 2001·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·J CarlileA M Schor
Jan 5, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Francesca TosettiAdriana Albini
Feb 13, 2002·Circulation·Michael WeisJohn P Cooke
Mar 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jennifer TranRobert S Kerbel
Apr 6, 2002·Circulation Research·Carmen UrbichStefanie Dimmeler
Dec 14, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Isabella Dell'AicaSpiridione Garbisa
Jun 6, 2003·Cancer Detection and Prevention·D BisacchiA Albini
Aug 7, 2003·Journal of Cell Science·Tejindervir S HiranSusan E LaFlamme
Feb 27, 2004·Nature·Judah Folkman, Raghu Kalluri
May 12, 2004·Nature Reviews. Drug Discovery·Napoleone FerraraWilliam Novotny
Jun 10, 2004·The Annals of Pharmacotherapy·Stacey D Zondor, Patrick J Medina
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alan B SandlerRoy S Herbst
Sep 24, 2004·Biochemical and Biophysical Research Communications·Chong FengMengfeng Li

❮ Previous
Next ❯

Citations

Jun 25, 2013·Expert Opinion on Investigational Drugs·Domenico Ribatti, Silvia Baiguera
Jan 27, 2010·Pharmacotherapy·Hazem F ElewaSusan C Fagan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Vascular Health and Risk Management
Navin K Kapur, Kiran Musunuru
Arquivos brasileiros de cardiologia
Alexandre Russo SpositoMarcelo Chiara Bertolami
© 2021 Meta ULC. All rights reserved